Company profileNutraceutical & supplements#100 of 1,318 in Pakistan✓ No DRAP alerts

Alaq Laboratories, Lahore

Nutraceutical & supplement manufacturer · 161 registered products

Ranked #45 of 62 companies in Antivirals For Systemic Use

161 registered products 6 distinct molecules 0 DRAP alerts
161 of this company's registrations sit in the DRAP category “Nutritional Supplement / Multivitamin”, which is registered as a category rather than by molecule — so a low molecule count reflects how supplements are registered, not a small portfolio. Nutraceutical manufacturers advertise direct to consumers and are among the largest marketing spenders in the Pakistani market.

Company overview

161
registered products
6
distinct molecules
1
therapeutic classes
0
DRAP alerts

Alaq Laboratories, Lahore is a nutraceutical and dietary-supplement manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 161 product registrations. It is the 100th largest registrant in Pakistan by product count, and ranks 45th of 62 in Antivirals For Systemic Use. Its portfolio is concentrated in Antivirals For Systemic Use. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Nutritional Supplement / Multivitamin161 brands
Ribavirin ...... 100 Mg1 brand
Ribavirin ...... 600 Mg1 brand
Ribavirin ...... 200 Mg1 brand
Ribavirin.........................400Mg1 brand
Ribavirin1 brand

Therapeutic classes

Antivirals For Systemic Use · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official4 products · Rs 225.24 – Rs 1,178.97
Median across source: Rs 607.09

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Get the full profile for Alaq

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.